Topical capsaicin for pain management: therapeutic potential and mechanisms of action of the new high-concentration capsaicin 8% patch

P Anand, K Bley - British journal of anaesthesia, 2011 - academic.oup.com
Topical capsaicin formulations are used for pain management. Safety and modest efficacy of
low-concentration capsaicin formulations, which require repeated daily self-administration …

Capsaicin and gut microbiota in health and disease

AE Rosca, MI Iesanu, CDM Zahiu, SE Voiculescu… - Molecules, 2020 - mdpi.com
Capsaicin is a widespread spice known for its analgesic qualities. Although a
comprehensive body of evidence suggests pleiotropic benefits of capsaicin, including anti …

Capsaicin 8% dermal patch in clinical practice: an expert opinion

C Bonezzi, A Costantini, G Cruccu… - Expert opinion on …, 2020 - Taylor & Francis
Introduction Neuropathic pain (NP) is caused by a lesion or disease of the somatosensory
system, which can severely impact patients' quality of life. The current-approved treatments …

A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy

DB Clifford, DM Simpson, S Brown… - JAIDS Journal of …, 2012 - journals.lww.com
Methods: In this randomized, double-blind, controlled study, patients with pain due to HIV-
associated distal sensory polyneuropathy received a single 30-minute or 60-minute …

NGX-4010, a capsaicin 8% dermal patch, administered alone or in combination with systemic neuropathic pain medications, reduces pain in patients with postherpetic …

GA Irving, M Backonja, R Rauck… - The Clinical journal …, 2012 - journals.lww.com
Objectives: Analyses of integrated data from 4 controlled postherpetic neuralgia studies
evaluated the effect of NGX-4010, a capsaicin 8% patch, administered alone or together with …

Capsaicin dermal patch: in non-diabetic peripheral neuropathic pain

PL McCormack - Drugs, 2010 - Springer
Capsaicin dermal patch is an adhesive patch containing a high concentration (8% w/w) of
synthetic capsaicin. It is indicated in the EU for the treatment of peripheral neuropathic pain …

The capsaicin 8% patch for neuropathic pain in clinical practice: a retrospective analysis

T Wagner, C Poole, A Roth-Daniek - Pain Medicine, 2013 - academic.oup.com
Objective To investigate the response of patients with peripheral neuropathic pain (PNP) to
capsaicin 8% patch treatment in a clinical setting. Design Retrospective analysis. Setting …

Development of capsaicin-containing analgesic silicone-based transdermal patches

S László, IZ Bátai, S Berkó, E Csányi, Á Dombi… - Pharmaceuticals, 2022 - mdpi.com
Transdermal therapeutic systems (TTSs) enable convenient dosing in drug therapy.
Modified silicone-polymer-based patches are well-controlled and cost-effective matrix …

NGX-4010, a capsaicin 8% patch, for the treatment of painful HIV-associated distal sensory polyneuropathy: integrated analysis of two phase III, randomized …

S Brown, DM Simpson, G Moyle, BJ Brew… - AIDS research and …, 2013 - Springer
Background HIV-associated distal sensory polyneuropathy (HIV-DSP) is the most frequently
reported neurologic complication associated with HIV infection. NGX-4010 is a capsaicin 8 …

Efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in an open-label study of patients with peripheral neuropathic pain

LR Webster, JF Peppin, FT Murphy, B Lu… - Diabetes Research and …, 2011 - Elsevier
AIMS: To assess efficacy, safety, and tolerability of NGX-4010, capsaicin 8% patch, in
patients with peripheral neuropathic pain. METHODS: This open-label, uncontrolled, 12 …